Global Arterial Stent
At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment
At cognitive, our research analyst works closely with Arterial Stent market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)
The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.
From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.
Report edition's total number of pages for pdf format (Approximate)
Rating and review received by the reader or subscriber of the said report.
Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.
As Cognitive a market research and consulting firm, we can provide Arterial Stent market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.
Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034 |
|---|---|
| Product Outlook: Segment Analysis | Coronary Stents, Bare Metal, Drug-Eluting, Bioresorbable, Peripheral Stents, Self-expandable, Balloon-expandable |
| Application Outlook: Segment Analysis | Coronary Artery, Carotid Artery, Iliac Artery, Femoral, Popliteal Artery |
| Regions & Countries Analysis |
|
|---|
Share your contact details to receive free updated sample copy/pages of the recently published edition of Arterial Stent Market Report 2025.
According to Cognitive Market Research, the global Arterial stent Market size will be USD 8562.9 million in 2025. It will expand at a compound annual growth rate (CAGR) of 3.00% from 2025 to 2033.
Market Drivers:
|
Market Restrains:
|
Market Trends:
|
| Market Size | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global Arterial Stent Market Sales Revenue | xxxx | $ 8562.9 Million | $ 10847.2 Million | 3% |
| North America Arterial Stent Market Sales Revenue | xxxx | $ 3168.27 Million | $ 3579.6 Million | 1.5% |
| United States Arterial Stent Market Sales Revenue | xxxx | $ 2499.77 Million | xxxx | 1.3% |
| Canada Arterial Stent Market Sales Revenue | xxxx | $ 380.19 Million | xxxx | 2.3% |
| Mexico Arterial Stent Market Sales Revenue | xxxx | $ 288.31 Million | xxxx | 2% |
| Europe Arterial Stent Market Sales Revenue | xxxx | $ 2483.24 Million | $ 2928.8 Million | 2.1% |
| United Kingdom Arterial Stent Market Sales Revenue | xxxx | $ 417.18 Million | xxxx | 2.9% |
| France Arterial Stent Market Sales Revenue | xxxx | $ 228.46 Million | xxxx | 1.3% |
| Germany Arterial Stent Market Sales Revenue | xxxx | $ 491.68 Million | xxxx | 2.3% |
| Italy Arterial Stent Market Sales Revenue | xxxx | $ 213.56 Million | xxxx | 1.5% |
| Russia Arterial Stent Market Sales Revenue | xxxx | $ 384.9 Million | xxxx | 1.1% |
| Spain Arterial Stent Market Sales Revenue | xxxx | $ 203.63 Million | xxxx | 1.2% |
| Sweden Arterial Stent Market Sales Revenue | xxxx | $ 76.98 Million | xxxx | 2.2% |
| Denmark Arterial Stent Market Sales Revenue | xxxx | $ 52.15 Million | xxxx | 1.9% |
| Switzerland Arterial Stent Market Sales Revenue | xxxx | $ 37.25 Million | xxxx | 1.7% |
| Luxembourg Arterial Stent Market Sales Revenue | xxxx | $ 29.8 Million | xxxx | 2.4% |
| Rest of Europe Arterial Stent Market Sales Revenue | xxxx | $ 347.65 Million | xxxx | 0.8% |
| Asia Pacific Arterial Stent Market Sales Revenue | xxxx | $ 2055.1 Million | $ 3183.7 Million | 5.6% |
| China Arterial Stent Market Sales Revenue | xxxx | $ 863.14 Million | xxxx | 5.1% |
| Japan Arterial Stent Market Sales Revenue | xxxx | $ 283.6 Million | xxxx | 4.1% |
| South Korea Arterial Stent Market Sales Revenue | xxxx | $ 246.61 Million | xxxx | 4.7% |
| India Arterial Stent Market Sales Revenue | xxxx | $ 205.51 Million | xxxx | 7.5% |
| Australia Arterial Stent Market Sales Revenue | xxxx | $ 106.86 Million | xxxx | 4.9% |
| Singapore Arterial Stent Market Sales Revenue | xxxx | $ 41.1 Million | xxxx | 5.9% |
| Taiwan Arterial Stent Market Sales Revenue | xxxx | $ 80.15 Million | xxxx | 5.4% |
| South East Asia Arterial Stent Market Sales Revenue | xxxx | $ 135.64 Million | xxxx | 6.4% |
| Rest of APAC Arterial Stent Market Sales Revenue | xxxx | $ 92.48 Million | xxxx | 5.4% |
| South America Arterial Stent Market Sales Revenue | xxxx | $ 325.39 Million | $ 433.9 Million | 3.7% |
| Brazil Arterial Stent Market Sales Revenue | xxxx | $ 139.27 Million | xxxx | 4.3% |
| Argentina Arterial Stent Market Sales Revenue | xxxx | $ 54.67 Million | xxxx | 4.6% |
| Colombia Arterial Stent Market Sales Revenue | xxxx | $ 28.96 Million | xxxx | 3.5% |
| Peru Arterial Stent Market Sales Revenue | xxxx | $ 26.68 Million | xxxx | 3.9% |
| Chile Arterial Stent Market Sales Revenue | xxxx | $ 23.43 Million | xxxx | 4% |
| Rest of South America Arterial Stent Market Sales Revenue | xxxx | $ 52.39 Million | xxxx | 2.8% |
| Middle East Arterial Stent Market Sales Revenue | xxxx | $ 342.52 Million | $ 477.3 Million | 4.2% |
| Qatar Arterial Stent Market Sales Revenue | xxxx | $ 27.4 Million | xxxx | 3.7% |
| Saudi Arabia Arterial Stent Market Sales Revenue | xxxx | $ 120.57 Million | xxxx | 4.5% |
| Turkey Arterial Stent Market Sales Revenue | xxxx | $ 27.4 Million | xxxx | 4.8% |
| UAE Arterial Stent Market Sales Revenue | xxxx | $ 70.56 Million | xxxx | 4.7% |
| Egypt Arterial Stent Market Sales Revenue | xxxx | $ 20.55 Million | xxxx | 4% |
| Rest of Middle East Arterial Stent Market Sales Revenue | xxxx | $ 76.04 Million | xxxx | 3.4% |
| Africa Arterial Stent Market Sales Revenue | xxxx | $ 188.38 Million | $ 244.1 Million | 3.3% |
| Nigeria Arterial Stent Market Sales Revenue | xxxx | $ 15.07 Million | xxxx | 3.5% |
| South Africa Arterial Stent Market Sales Revenue | xxxx | $ 66.31 Million | xxxx | 4.2% |
Arterial Stent Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The arterial stent market refers to the global industry focused on the development, production, and sale of stents designed for use in arteries to treat conditions such as atherosclerosis, coronary artery disease, and peripheral artery disease. An arterial stent is a small, mesh-like medical device typically made from metal or polymer that is inserted into narrowed or blocked arteries to restore and maintain proper blood flow. These stents can be categorized into several types, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents, each offering specific benefits based on patient needs and clinical applications. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in stent technology, aging populations, and rising demand for minimally invasive procedures. Key players in this market focus on innovation, particularly in drug-eluting technologies and bioresorbable materials, to improve patient outcomes and reduce complications like restenosis. Additionally, government initiatives promoting cardiovascular health and growing healthcare infrastructure in emerging economies contribute to market expansion
In April 2021 - BIOTRONIK announced the launch of its newest suite of tools for the more specialized implanting procedures in the His-bundle cardiac conduction system. https://www.dicardiology.com/content/biotronik-launches-his-bundle-pacing-tools
The growing aging population is a significant driver of the arterial stent market, as age is a key risk factor for cardiovascular diseases (CVDs) and arterial blockages. As people age, their arteries naturally lose elasticity, and the likelihood of developing conditions such as atherosclerosis increases due to factors like plaque buildup, high cholesterol, and hypertension. This leads to a higher incidence of arterial blockages, necessitating medical interventions such as stent placements to restore proper blood flow and prevent severe complications like heart attacks or strokes. According to global health data, the prevalence of CVDs rises sharply in individuals over 65, making this demographic a primary target for arterial stent procedures. Additionally, advancements in healthcare infrastructure and greater awareness of heart health among older people have increased the demand for early diagnosis and intervention.
Technological advancements in stent design are a significant driver of growth in the arterial stent market, as they continually enhance the effectiveness and safety of these life-saving devices. Innovations such as drug-eluting stents (DES), bioresorbable stents, and advanced coatings have revolutionized treatment outcomes by reducing restenosis rates and minimizing the risk of thrombosis. The integration of cutting-edge materials like cobalt-chromium and platinum-chromium alloys has improved stent flexibility, durability, and visibility under imaging, facilitating more precise placement during procedures. Additionally, the development of next-generation biodegradable stents offers the promise of supporting arterial healing without leaving permanent implants, reducing long-term complications. Enhanced delivery systems and imaging-guided deployment techniques have also contributed to safer and more efficient procedures, leading to quicker patient recovery times.
The high cost of arterial stent procedures serves as a significant restraint on market growth, particularly limiting accessibility for patients in low-income regions. These procedures often involve expensive medical devices, advanced technology, and specialized healthcare professionals, driving up overall treatment costs. Additionally, the need for high-end diagnostic tools, post-operative care, and potential follow-up procedures further increases the financial burden on patients and healthcare systems. In many developing countries, limited insurance coverage and underfunded public healthcare systems exacerbate this issue, leaving many patients unable to afford necessary treatments. This financial barrier not only restricts patient access but also discourages healthcare providers from investing in advanced stent technologies due to uncertain returns in cost-sensitive markets.
The technological advancements, rising cardiovascular disease prevalence, and a growing emphasis on minimally invasive procedures. One significant trend is the increasing adoption of drug-eluting stents (DES), which release medication to prevent restenosis and have shown superior long-term outcomes compared to bare-metal stents (BMS). Bioabsorbable stents are also gaining traction, offering temporary scaffolding that dissolves over time, reducing long-term complications. Additionally, personalized stent solutions, including patient-specific designs created using advanced imaging and 3D printing, are emerging as a game-changer for complex cases. There is also rising interest in dual-therapy stents that combine drug elution with pro-healing technologies to enhance vascular recovery.
We have various report editions of Arterial Stent Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The arterial stent market is highly competitive, driven by technological advancements, increasing cardiovascular disease prevalence, and rising demand for minimally invasive procedures. Key players like Boston Scientific, Medtronic, Abbott Laboratories, Terumo Corporation, and B. Braun Melsungen AG dominate the market with strong portfolios and global distribution networks. Innovation is a major competitive factor, with companies investing heavily in next-generation drug-eluting stents (DES), bioresorbable stents, and advanced materials to enhance patient outcomes and reduce restenosis rates. Emerging players and startups are also gaining traction by focusing on niche innovations and regional markets.
In May 2022 - Medtronic plc announced it received US Food and Drug Administration (FDA) approval for the Onyx FrontierTM drug-eluting stent (DES). As the latest evolution in the Resolute DES family, Onyx Frontier DES leverages the same best-in-class stent platform as Resolute OnyxTM DES, with an enhanced delivery system1 designed to improve deliverability and increase acute performance2 in even the most challenging of cases.1 https://news.medtronic.com/2022-05-13-Medtronic-receives-FDA-approval-for-latest-generation-drug-eluting-coronary-stent-system In October 2021, Boston Scientific Corporation announced positive data for the EluviaTM Drug-Eluting Vascular Stent System (Eluvia stent), demonstrating its superiority compared to self-expanding bare metal stents (BMS) for the treatment of patients with peripheral artery disease (PAD) and superficial femoral artery (SFA) or popliteal artery (PPA) lesions up to 210 mm in length. https://news.bostonscientific.com/2021-10-06-Boston-Scientific-Eluvia-TM-Drug-Eluting-Vascular-Stent-System-Exhibits-Superiority-Compared-to-Bare-Metal-Stents
Top Companies Market Share in Arterial Stent Industry: (In no particular order of Rank)
| Companies | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Medtronic | xxxx | xxxx | xxxx | xxxx |
| Abbott Laboratories | xxxx | xxxx | xxxx | xxxx |
| Boston Scientific Corporation | xxxx | xxxx | xxxx | xxxx |
| Terumo Corporation | xxxx | xxxx | xxxx | xxxx |
| B Braun Melsungen AG | xxxx | xxxx | xxxx | xxxx |
| Biotronik | xxxx | xxxx | xxxx | xxxx |
| Stentys SA | xxxx | xxxx | xxxx | xxxx |
| MicroPort Scientific Corporation | xxxx | xxxx | xxxx | xxxx |
| C. R. Bard Inc. | xxxx | xxxx | xxxx | xxxx |
| Cook Medical | xxxx | xxxx | xxxx | xxxx |
*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)
Request Any Company Profile for Preview Purpose OR Data Validation!
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Arterial stent Market, and the region is expected to have a rising prevalence of cardiovascular diseases, technological advancements, and an aging population. The United States dominates the regional market due to high healthcare spending, advanced medical infrastructure, and increased awareness of minimally invasive procedures. Factors such as a growing geriatric population, lifestyle-related health issues like obesity and hypertension, and favorable reimbursement policies further fuel market expansion. Canada also contributes significantly, with increasing investments in healthcare and a focus on improving cardiovascular treatment outcomes.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). This is rising cardiovascular disease prevalence, increasing healthcare expenditure, and advancements in medical technology. Countries like China, Japan, India, and South Korea are at the forefront of this expansion, fueled by aging populations, lifestyle changes, and growing awareness of early disease detection. China leads the market due to its large patient pool and government investments in healthcare infrastructure. India follows closely, with rapid urbanization and improved access to medical services driving demand. Japan, with its advanced healthcare system, continues to adopt cutting-edge technologies, contributing to market growth.
The current report Scope analyzes Arterial Stent Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Arterial stent Market size was estimated at USD 43521.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 3168.27 million in 2025 and will grow at a compound annual growth rate (CAGR) of 1.5% from 2025 to 2033.
According to Cognitive Market Research, the US had a major share in the Arterial stent Market with a market size of USD 2499.77 million in 2025 and is projected to grow at a CAGR of 1.3% during the forecast period. The U.S. Market's Technological Integration of AI and Robotics in Surgery.
The Canadian Arterial stent Market had a market share of USD 380.19 million in 2025 and is projected to grow at a CAGR of 2.3% during the forecast period. Canada’s Rising Demand for Outpatient Surgeries.
The Mexico Arterial stent Market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 288.31 million in 2025..
According to Cognitive Market Research, the global Arterial stent Market size was estimated at USD 8562.9 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 13056.48 million in 2025 and will grow at a compound annual growth rate (CAGR) of 2.1% from 2025 to 2033.
The United Kingdom Arterial Stent Market had a market share of USD 417.18 million in 2025 and is projected to grow at a CAGR of 2.9% during the forecast period. In the UK, Arterial stent sales Growing prevalence of lifestyle-related health issues like obesity.
The France Arterial stent Market is projected to witness growth at a CAGR of 1.3% during the forecast period, with a market size of USD 228.46 million in 2025.
According to Cognitive Market Research, the German Arterial stent Market size was valued at USD 491.68 million in 2025 and is projected to grow at a CAGR of 2.3% during the forecast period. In Germany, Increasing investments in research and development
The Italy Arterial stent Market is projected to witness growth at a CAGR of 1.5% during the forecast period, with a market size of USD 213.56 million in 2025.
The Russian arterial stent Market is projected to witness growth at a CAGR of 1.1% during the forecast period, with a market size of USD 384.90 million in 2025
The Spain Arterial stent Market is projected to witness growth at a CAGR of 1.2% during the forecast period with a market size of USD 203.63 million in 2025
The Sweden Arterial stent Market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 76.98 million in 2025.
The Denmark Arterial stent Market is projected to witness growth at a CAGR of 1.9% during the forecast period, with a market size of USD 52.15 million in 2025
The Switzerland Arterial stent Market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 37.25 million in 2025.
The Luxembourg Arterial stent Market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 29.80 million in 2025.
The Rest of Europe's Arterial stent Market is projected to witness growth at a CAGR of 0.8% during the forecast period, with a market size of USD 347.65 million in 2025.
According to Cognitive Market Research, the global Arterial stent Market size was estimated at USD 8562.9 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 2055.10 million in 2025 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2033.
According to Cognitive Market Research, the China Arterial Stent Market size was valued at USD 863.14 million in 2025 and is projected to grow at a CAGR of 5.1% during the forecast period. Arterial stent Favorable government initiatives and healthcare policies.
The Japan Arterial stent Market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 283.60 million in 2025
The South Korea Arterial Stent Market had a market share of USD 246.61 million in 2025 and is projected to grow at a CAGR of 4.7% during the forecast period. India's Rising Adoption of Biodegradable Stents.
The Indian Arterial stent Market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 205.51 million in 2025.
The Australian Arterial stent Market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 106.86 million in 2025.
The Singapore Arterial stent Market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 41.10 million in 2025.
The Taiwan Arterial stent Market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 80.15 million in 2025.
The South East Asia Arterial stent Market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 135.64 million in 2025.
The Rest of APAC Arterial stent Market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 92.48 million in 2025.
According to Cognitive Market Research, the global Arterial stent Market size was estimated at USD 8562.9 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 325.39 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2025 to 2033.
According to Cognitive Market Research, the Brazil Arterial Stent Market size was valued at USD 139.27 million in 2025 and is projected to grow at a CAGR of 4.3% during the forecast period. Arterial stent Expansion of healthcare infrastructure in emerging markets.
Argentina's Arterial stent Market had a market share of USD 54.67 million in 2025 and is projected to grow at a CAGR of 4.6% during the forecast period. Argentina's Growing awareness of minimally invasive procedures.
Colombia Arterial stent Market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 28.96 million in 2025
Peru Arterial stent Market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 26.68 million in 2025.
Chile Arterial stent Market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 23.43 million in 2025
The Rest of South America's Arterial stent Market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 52.39 million in 2025.
According to Cognitive Market Research, the global Arterial stent Market size was estimated at USD 8562.9 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 342.52 million in 2025 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2033..
The Qatar Arterial Stent Market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 27.40 million in 2025. Arterial stent sales Advancements in stent technology, including drug-eluting stents.
The Saudi Arabia Arterial stent Market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 120.57 million in 2025.
The Turkey Arterial Stent Market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 27.40 million in 2025. Arterial stent sales Increasing geriatric population susceptible to heart conditions.
The UAE Arterial stent Market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 70.56 million in 2025.
The Egypt Arterial stent Market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 20.55 million in 2025.
The Rest of the Middle East Arterial stent Market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 76.04 million in 2025
According to Cognitive Market Research, the global Arterial stent Market size was estimated at USD 8562.9 Million, out of which Africa held the major market share of around 2% of the global revenue with a market size of USD 188.38 million in 2025 and will grow at a compound annual growth rate (CAGR) of 3.3% from 2025 to 2033..
The Nigeria Arterial Stent Market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 15.07 million in 2025. Arterial stent sales Rising prevalence of cardiovascular diseases globally.
The South Africa Arterial stent Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 66.31 million in 2025.
The Rest of Africa Arterial Stent Market is projected to witness growth at a CAGR of 2.5% during the forecast period, with a market size of USD 107.00 million in 2025.
Conclusion
Research Analyst at Cognitive Market Research
LinkedIn | Profile | Book Appointment
Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
Global Arterial Stent Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Arterial Stent Industry growth. Arterial Stent market has been segmented with the help of its Product Outlook:, Application Outlook: , and others. Arterial Stent market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Arterial Stent Market?
According to Cognitive Market Research, Coronary Stents dominate the market due to the high prevalence of cardiovascular diseases, including coronary artery disease (CAD), which remains a leading cause of death globally. These stents are primarily used to open narrowed or blocked coronary arteries, improving blood flow to the heart. Technological advancements, such as drug-eluting stents (DES) and bioresorbable stents, have significantly enhanced patient outcomes by reducing restenosis rates. The growing aging population, coupled with lifestyle-related risk factors like hypertension and obesity, further drives demand for coronary stents.
Peripheral Stents, on the other hand, are used to treat peripheral artery disease (PAD), which affects arteries outside the heart, primarily in the legs. Rising incidences of diabetes and smoking-related conditions contribute to the growth of this segment. Innovations like drug-coated balloons and self-expanding stents have improved treatment efficacy. While this segment holds a smaller market share compared to coronary stents, it is expected to witness significant growth due to increased awareness and early diagnosis of PAD.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Arterial Stent Industry. Request a Free Sample PDF!
According to Cognitive Market Research, Coronary artery stents dominate the market due to the high prevalence of coronary artery disease (CAD), driven by lifestyle factors such as poor diet, smoking, and sedentary behavior. These stents are primarily used to restore blood flow in narrowed or blocked coronary arteries, reducing the risk of heart attacks. The segment benefits from continuous technological advancements, such as drug-eluting stents (DES) and bioresorbable stents, which enhance patient outcomes by minimizing restenosis and thrombosis risks.
In the Arterial stent Market, the carotid artery stents cater to patients at risk of stroke due to carotid artery stenosis. Although this segment holds a smaller market share, it is growing steadily due to the increasing aging population and advancements in minimally invasive procedures. Carotid stenting offers a less invasive alternative to carotid endarterectomy, making it a preferred choice for high-risk surgical patients.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Disclaimer:
| Product Outlook: | Coronary Stents, Bare Metal, Drug-Eluting, Bioresorbable, Peripheral Stents, Self-expandable, Balloon-expandable |
| Application Outlook: | Coronary Artery, Carotid Artery, Iliac Artery, Femoral, Popliteal Artery |
| List of Competitors | Medtronic, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard Inc., Cook Medical |
Chapter 1 2026 Geopolitical Outlook - Arterial Stent Market Detailed Analysis
This chapter isn't just about technology; it’s about certainty. We show you how AI is being used in leading industries so you can apply those same 'High-Speed' and 'High-Accuracy' principles to your own market strategy
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
This chapter will help you gain GLOBAL Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review Global Arterial Stent Market Split by various segments and Geographical Split.
Chapter 3 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review North America Arterial Stent Market Split by various segments and Country Split.
Chapter 4 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review Europe Arterial Stent Market Split by various segments and Country Split.
Chapter 5 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review Asia Pacific Arterial Stent Market Split by various segments and Country Split.
Chapter 6 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review South America Arterial Stent Market Split by various segments and Country Split.
Chapter 7 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review Middle East Arterial Stent Market Split by various segments and Country Split.
Chapter 8 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Arterial Stent. Further deep in this chapter, you will be able to review Middle East Arterial Stent Market Split by various segments and Country Split.
Chapter 9 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Arterial Stent. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 11 Qualitative Analysis (Subject to Data Availability)
Segmentation Product Outlook: Analysis 2019 -2031, will provide market size split by Product Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Product Outlook: Analysis 2022 - 2034
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Application Outlook: Analysis 2022 - 2034
Chapter 14 Arterial Stent Price Trend Analysis
Chapter 15 Arterial Stent Import/Export Analysis
Chapter 16 Arterial Stent Production Analysis
Chapter 17 Gap Analysis
Chapter 18 Strategy Analysis
Chapter 19 Profitability and Gross Margin Analysis
Chapter 20 TAM Analysis
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Arterial Stent market
Chapter 21 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 22 Research Methodology and Sources
1 Data Gathering
2 Data Validation
3 Data Presentation
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.